State Street Corp Age X Therapeutics, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.57 - $1.0 $34 - $60
-60 Reduced 0.22%
26,801 $15,000
Q2 2021

Aug 16, 2021
BUY
$1.14 - $1.77 $30,621 - $47,543
26,861 New
26,861 $42,000
Q2 2020

Aug 14, 2020
SELL
$0.68 - $1.13 $199,843 - $332,093
-293,888 Closed
0 $0
Q1 2020

May 11, 2020
BUY
$0.78 - $1.95 $229,232 - $573,081
293,888 New
293,888 $273,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email